Search details
1.
Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
Proc Natl Acad Sci U S A
; 114(52): 13792-13797, 2017 12 26.
Article
in English
| MEDLINE | ID: mdl-29229854
2.
The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer.
Breast Cancer Res
; 21(1): 54, 2019 04 29.
Article
in English
| MEDLINE | ID: mdl-31036052
3.
Breaking the oncostatin M feed-forward loop to suppress metastasis and therapy failure.
J Pathol
; 245(1): 6-8, 2018 May.
Article
in English
| MEDLINE | ID: mdl-29473175
4.
DNMT1-associated long non-coding RNAs regulate global gene expression and DNA methylation in colon cancer.
Hum Mol Genet
; 24(21): 6240-53, 2015 Nov 01.
Article
in English
| MEDLINE | ID: mdl-26307088
5.
IFNß-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.
EMBO J
; 32(20): 2751-63, 2013 Oct 16.
Article
in English
| MEDLINE | ID: mdl-24065129
6.
TGF-beta signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells.
Proc Natl Acad Sci U S A
; 108(21): 8668-73, 2011 May 24.
Article
in English
| MEDLINE | ID: mdl-21555587
7.
Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine Glycogen Storage Disease type Ia.
Mol Genet Metab
; 109(2): 161-70, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23623482
8.
Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65.
Proc Natl Acad Sci U S A
; 107(1): 46-51, 2010 Jan 05.
Article
in English
| MEDLINE | ID: mdl-20080798
9.
How cancer cells make and respond to interferon-I.
Trends Cancer
; 9(1): 83-92, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36216730
10.
Oncostatin-M and OSM-Receptor Feed-Forward Activation of MAPK Induces Separable Stem-like and Mesenchymal Programs.
Mol Cancer Res
; 21(9): 975-990, 2023 09 01.
Article
in English
| MEDLINE | ID: mdl-37310811
11.
Validation-based insertional mutagenesis identifies lysine demethylase FBXL11 as a negative regulator of NFkappaB.
Proc Natl Acad Sci U S A
; 106(38): 16339-44, 2009 Sep 22.
Article
in English
| MEDLINE | ID: mdl-19805303
12.
Validation-Based Insertional Mutagenesis (VBIM), A Powerful Forward Genetic Screening Strategy.
Curr Protoc
; 2(3): e394, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35316583
13.
DNA synthesis from unbalanced nucleotide pools causes limited DNA damage that triggers ATR-CHK1-dependent p53 activation.
Proc Natl Acad Sci U S A
; 105(17): 6314-9, 2008 Apr 29.
Article
in English
| MEDLINE | ID: mdl-18434539
14.
Aberrant Induction of a Mesenchymal/Stem Cell Program Engages Senescence in Normal Mammary Epithelial Cells.
Mol Cancer Res
; 19(4): 651-666, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33443106
15.
MYO10 drives genomic instability and inflammation in cancer.
Sci Adv
; 7(38): eabg6908, 2021 Sep 17.
Article
in English
| MEDLINE | ID: mdl-34524844
16.
SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness.
Life Sci Alliance
; 3(4)2020 04.
Article
in English
| MEDLINE | ID: mdl-32071280
17.
Inflammation mobilizes copper metabolism to promote colon tumorigenesis via an IL-17-STEAP4-XIAP axis.
Nat Commun
; 11(1): 900, 2020 02 14.
Article
in English
| MEDLINE | ID: mdl-32060280
18.
p53-mediated growth suppression in response to Nutlin-3 in cyclin D1 transformed cells occurs independently of p21.
Cancer Res
; 67(20): 9862-8, 2007 Oct 15.
Article
in English
| MEDLINE | ID: mdl-17942917
19.
Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1alpha and Hdm2.
Cancer Res
; 67(2): 450-4, 2007 Jan 15.
Article
in English
| MEDLINE | ID: mdl-17234751
20.
Balancing STAT Activity as a Therapeutic Strategy.
Cancers (Basel)
; 11(11)2019 Nov 03.
Article
in English
| MEDLINE | ID: mdl-31684144